--- title: "The Island of Misfit Tech and Legacy Bets: Who's Actually Delivering in 2026?" type: "News" locale: "en" url: "https://longbridge.com/en/news/297645148.md" description: "This eclectic mix of ten peripheral players offers a stark reality check in 2026. While legacy operators like Dingdong and PBF Energy are churning out solid cash flows, others are still peddling tired AI and eVTOL dreams without the math to back them up." datetime: "2026-09-01T11:33:13.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/297645148.md) - [en](https://longbridge.com/en/news/297645148.md) - [zh-HK](https://longbridge.com/zh-HK/news/297645148.md) generator: "portal-rs" --- # The Island of Misfit Tech and Legacy Bets: Who's Actually Delivering in 2026? This is stupid and here's why. We're looking at a bizarre grab bag of ten peripheral market players in 2026, and the divergence in their survival instincts is glaring. When capital tightens, you can't fake it with buzzwords anymore—you either have cash flow or you're dead weight. Let's start with the rare bright spots. Dingdong (DDL.US) is actually making money selling groceries. They just posted their tenth consecutive profitable quarter in Q2 2026, with net income skyrocketing 153.5% to CNY 271.7M. In a sector famous for incinerating cash, focusing on private-label goods and frontline fulfillment is exactly the kind of unsexy operational discipline that wins. PBF Energy (PBF.US) is pulling a similar legacy flex. Trimming over USD 1B in debt while posting Q2 operating income of USD 1.27B is serious business. They got their California refinery back online and are keeping their heads down. To the founders burning venture money on vanity projects: why aren't you moving faster? Speaking of vanity, Vertical Aerospace (VRTL.US) and the rest of the eVTOL crowd are still promising us flying cars while the runway gets painfully short. Similarly, Genpact (GENB.US) and MicroAlgo (MLGO.US) are swimming in the B2B digital and AI algorithm soup, yet offering virtually zero substantial recent numbers to prove they aren't just coasting on the hype cycle. Good luck with that. Then we have the scrappers. Taoping (TAOP.US) managed to scrape together a USD 5.2M smart elevator order in July, only to violently shake up their leadership in August by axing both their President and CMO. Drama much? Meanwhile, Netlist (NLST.US) is running a legal circus. They burned about 73% of their Q2 gross profit on IP litigation. At least they finally struck a strategic alliance with Samsung in August before immediately dragging Micron to the ITC over AI memory patents. On the commodities front, Hycroft Mining (HYMC.US) is surviving the cycle, expanding its high-grade silver mineralization in August and flaunting a strong balance sheet after bringing in a new COO. GSK (GSK.US) remains the towering outlier here, sitting on over GBP 32.7B in 2025 sales and methodically grinding through its biopharma pipeline. Lastly, The Cheesecake Factory (CAKE.US) is doing what it always does: surviving on massive menus and pure inertia. The reality is simple. The era of free money masking bad business models is over. Adapt or die. *This article does not constitute investment advice.* ### Related Stocks - [DDL.US](https://longbridge.com/en/quote/DDL.US.md) - [PBF.US](https://longbridge.com/en/quote/PBF.US.md) - [GENB.US](https://longbridge.com/en/quote/GENB.US.md) - [MLGO.US](https://longbridge.com/en/quote/MLGO.US.md) - [TAOP.US](https://longbridge.com/en/quote/TAOP.US.md) - [NLST.US](https://longbridge.com/en/quote/NLST.US.md) - [HYMC.US](https://longbridge.com/en/quote/HYMC.US.md) - [GSK.US](https://longbridge.com/en/quote/GSK.US.md) - [CAKE.US](https://longbridge.com/en/quote/CAKE.US.md) ## Related News & Research - [GSK to advance mRNA flu vaccine to late-stage trial](https://longbridge.com/en/news/297605972.md) - [GSK Says Immune Response from mRNA Flu Shot Surpasses Licensed Competitors](https://longbridge.com/en/news/297654888.md) - [Hycroft Strengthens Board for Its Next Phase of Growth | HYMC Stock News](https://longbridge.com/en/news/297696969.md) - [ViiV Healthcare wins FDA approval for Tivicay PD in pediatric HIV patients weighing at least 2 kg](https://longbridge.com/en/news/297059914.md) - [Is PBF Energy's (PBF) Refining Scale an Advantage or a Flexibility Test in Tight Markets?](https://longbridge.com/en/news/296888161.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**